Literature DB >> 8221676

Biophysical characterization of one-, two-, and three-tandem repeats of human mucin (muc-1) protein core.

J D Fontenot1, N Tjandra, D Bu, C Ho, R C Montelaro, O J Finn.   

Abstract

Until recently mucin tandem repeat protein cores were believed to exist in random-coil conformations and to attain structure solely by the addition of carbohydrates to serine and threonine residues. Matsushima et al. (Proteins Struct. Funct. Genet., 7: 125-155, 1990) recently proposed a model of the secondary structure of proline rich tandem repeat proteins that has challenged this idea, especially for the case of the human polymorphic epithelial mucin encoded by the muc-1 gene. We report here results of structural analyses of the muc-1 protein core by using synthetic peptide analogues. Synthetic peptides were prepared to correspond to one-, two-, and three-tandem repeats of muc-1. Results of one- and two-dimensional 1H NMR correlation spectroscopy on these peptides confirm that the muc-1 protein core is not a random-coil secondary structure. Long-lived amide protons are protected in D2O, and increasing spectral complexity in the region of the beta-protons of Asp2 and His 15 reveals that structural changes are occurring as the number of repeats increases. The greatest changes occur when the number of repeats increases from one to two. These results are supported by the reactivity of a panel of monoclonal antibodies raised against tumor associated muc-1 with these synthetic peptides in enzyme-linked immunosorbent assay. The primary immunodominant mucin epitope, PDTRP, does not appear to attain a native conformation in the single repeat peptide (20 amino acids, starting with P), but is expressed on peptides with multiple repeats. Intrinsic viscosity measurements of the peptide containing three repeats indicate that an ordered structure present in solution is rod shaped. The circular dichroism spectrum of the same peptide is dominated by proline in the trans conformation. These results are all consistent with the prediction that the muc-1 tandem repeat polypeptide core forms a polyproline beta-turn helix.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8221676

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  26 in total

1.  Large-scale analysis of intrinsic disorder flavors and associated functions in the protein sequence universe.

Authors:  Marco Necci; Damiano Piovesan; Silvio C E Tosatto
Journal:  Protein Sci       Date:  2016-10-25       Impact factor: 6.725

2.  Differential expression of MUC1 on transfected cell lines influences its recognition by MUC1 specific T cells.

Authors:  J Magarian-Blander; R P Hughey; C Kinlough; P A Poland; O J Finn
Journal:  Glycoconj J       Date:  1996-10       Impact factor: 2.916

Review 3.  MUC1 and MUC4: switching the emphasis from large to small.

Authors:  Huguette Albrecht; Kermit L Carraway
Journal:  Cancer Biother Radiopharm       Date:  2011-06       Impact factor: 3.099

Review 4.  MUC1 (CD227): a multi-tasked molecule.

Authors:  Vasso Apostolopoulos; Lily Stojanovska; Sharron E Gargosky
Journal:  Cell Mol Life Sci       Date:  2015-08-21       Impact factor: 9.261

Review 5.  MUC1-mediated motility in breast cancer: a review highlighting the role of the MUC1/ICAM-1/Src signaling triad.

Authors:  Lacey Haddon; Judith Hugh
Journal:  Clin Exp Metastasis       Date:  2015-03-11       Impact factor: 5.150

6.  Influence of the amino acid sequence on the MUC5AC motif peptide O-glycosylation by human gastric UDP-GalNAc:polypeptide N-acetylgalactosaminyltransferase(s).

Authors:  S Hennebicq; D Tetaert; B Soudan; A Boersma; G Briand; C Richet; J Gagnon; P Degand
Journal:  Glycoconj J       Date:  1998-03       Impact factor: 2.916

7.  Synthesis and structural characterization of the peptide epitope of the ovarian cancer biomarker CA125 (MUC16).

Authors:  Zach T Berman; Lee J Moore; Kathleen E Knudson; Rebecca J Whelan
Journal:  Tumour Biol       Date:  2010-06-22

8.  Therapeutic potential of a tumor-specific, MHC-unrestricted T-cell receptor expressed on effector cells of the innate and the adaptive immune system through bone marrow transduction and immune reconstitution.

Authors:  Nehad M Alajez; Jan Schmielau; Mark D Alter; Michael Cascio; Olivera J Finn
Journal:  Blood       Date:  2005-03-03       Impact factor: 22.113

9.  Induction of cellular immunity in chimpanzees to human tumor-associated antigen mucin by vaccination with MUC-1 cDNA-transfected Epstein-Barr virus-immortalized autologous B cells.

Authors:  G Pecher; O J Finn
Journal:  Proc Natl Acad Sci U S A       Date:  1996-02-20       Impact factor: 11.205

10.  Structural features of the human salivary mucin, MUC7.

Authors:  T L Gururaja; N Ramasubbu; P Venugopalan; M S Reddy; K Ramalingam; M J Levine
Journal:  Glycoconj J       Date:  1998-05       Impact factor: 2.916

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.